Delivery Order SPE2DB22D1202-SPE2DB25FUTT5
Award Date
2/26/25
Potential Completion Date
2/27/25
Potential Value
$33K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,778.62, is for the delivery of Moxifloxacin HCL 400 mg tablets. The contract is a Firm Fixed Price Delivery Order with a period of performance through July 10, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,104.21 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565457340 moxifloxacin HCL 400 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA to efficiently procure a comprehensive range of medical commodities to support military treatment...
This is a federal contract award from the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp for the delivery of 4,567,049,952 units of the pharmaceutical product Moxifloxacin HCL 400 mg tablets. The contract has a ceiling value of $3,342.70 and is a firm fixed price delivery order without any set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that maintains a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The award is for the delivery of moxifloxacin, a 400 mg/250 ml antibiotic medication, with a ceiling value of $1,075.38 and an ultimate completion date of September 3, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,722.55 firm fixed-price delivery order is for 50 units of the medication Moxifloxacin HCl 400 mg Tablet. The contract has an ultimate completion date of July 2, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $1,013.60 firm fixed-price contract is for the delivery of 4,564,603,860 tablets of the antibiotic moxifloxacin hydrochloride 400 milligrams. The contract has an ultimate completion date of May 15, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,677.11, is for the delivery of 4565259159 moxifloxacin HCL 400 mg tablets. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA Troop Support Medical to efficiently procure a comprehensive range of medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $59,726.47 firm fixed-price delivery order is for the supply of 4,565,213,771 units of Moxifloxacin HCL 400 mg tablets. The contract has an ultimate completion date of July 23, 2024 and was awarded on July 22, 2024 with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,493,731 units of Moxifloxacin HCL 400 mg tablets. The contract has a potential value of $11,963.26 and a completion date of February 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations associated with this award. This delivery order is issued...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,943,716 tablets of moxifloxacin hydrochloride 400 mg. The $2,662.92 contract has a period of performance through March 13, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with a $999,999,999.00 ceiling value through December 31, 2025 to deliver...